{"id":"W4409886694","doi":"10.1038/s41598-025-99376-z","title":"Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma","year":2025,"lang":"en","type":"erratum","venue":"Scientific Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Renal cell carcinoma; Immunotherapy; microRNA; Oncology; Medicine; Cancer research; First line; Line (geometry); Internal medicine; Immunology; Biology; Cancer; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003861721,0.001612182,0.0013033,0.002134932,0.00153066,0.001954769,0.002185855,0.0038424,0.04105861],"category_scores_gemma":[0.05085923,0.0007018553,0.001227225,0.001614468,0.0009616608,0.0009657977,0.00115309,0.005785313,0.0185596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001858807,"about_ca_system_score_gemma":0.002898909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008214738,"about_ca_topic_score_gemma":0.009690247,"domain_scores_codex":[0.9969372,0.0005138395,0.0005204373,0.0005571046,0.001241424,0.0002300477],"domain_scores_gemma":[0.9817566,0.007202778,0.0007341892,0.0009398459,0.008720613,0.0006460408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006654228,0.000008128952,0.0002118759,0.0001259384,0.00002158829,0.000398173,0.0000285116,0.00005285961,0.0001025382,0.000302355,0.9915264,0.007155024],"study_design_scores_gemma":[0.0002144314,0.00006239743,0.002936447,0.0007319938,0.0001920613,0.004204118,0.0001429117,0.0009025824,0.001881733,0.002361236,0.9862796,0.00009048545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0007821586,0.0009837359,0.002031707,0.06326679,0.9256499,0.00004146946,0.003995843,0.0007213187,0.002526961],"genre_scores_gemma":[0.0771073,0.01297829,0.01896149,0.1489678,0.4432666,0.0005757747,0.01803788,0.005223091,0.2748818],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.04105861,"threshold_uncertainty_score":0.1373547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0216887838872668,"score_gpt":0.2617994861399789,"score_spread":0.2401107022527121,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}